Latest Insider Transactions at Daxor Corp (DXR)
This section provides a real-time view of insider transactions for Daxor Corp (DXR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DAXOR CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DAXOR CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2024
|
Jonathan Adam Feldschuh Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
32,000
+47.12%
|
-
|
|
Dec 06
2024
|
Michael Richard Feldschuh Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
45,000
+17.82%
|
-
|
|
Mar 27
2024
|
Robert J Michel Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
750
+6.22%
|
$6,000
$8.7 P/Share
|
|
Mar 04
2024
|
Edward Feuer Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$7,000
$7.21 P/Share
|
|
Dec 06
2023
|
Robert J Michel Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
120
+1.12%
|
$840
$7.75 P/Share
|
|
Dec 01
2023
|
Robert J Michel Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
180
+1.7%
|
$1,260
$7.75 P/Share
|
|
Dec 01
2023
|
Michael Richard Feldschuh Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
800
+0.49%
|
$5,600
$7.8 P/Share
|
|
Nov 24
2023
|
Robert J Michel Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
500
+4.65%
|
$3,500
$7.94 P/Share
|
|
Nov 21
2023
|
Michael Richard Feldschuh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
84
+0.05%
|
$588
$7.65 P/Share
|
|
Nov 10
2023
|
Michael Richard Feldschuh Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,001
+0.62%
|
$7,007
$7.83 P/Share
|
|
Nov 09
2023
|
Michael Richard Feldschuh Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
401
+0.25%
|
$2,807
$7.85 P/Share
|
|
Oct 31
2023
|
Robert J Michel Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+17.02%
|
-
|
|
Oct 13
2023
|
Robert J Michel Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
500
+6.06%
|
$4,500
$9.02 P/Share
|
|
Sep 18
2023
|
Of Joseph Feldschuh Estate > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
25,000
-0.97%
|
-
|
|
May 24
2023
|
Joy S. Goudie Director |
BUY
Open market or private purchase
|
Direct |
300
+50.0%
|
$2,700
$9.75 P/Share
|
|
May 24
2023
|
Michael Richard Feldschuh Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+1.23%
|
$18,000
$9.75 P/Share
|
|
Mar 27
2023
|
Robert J Michel Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,750
+23.99%
|
-
|
|
Nov 18
2022
|
Robert J Michel Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+12.12%
|
$10,000
$10.0 P/Share
|
|
Nov 17
2022
|
Caleb Des Rosiers Director |
BUY
Open market or private purchase
|
Direct |
3,157
+50.0%
|
$28,413
$9.5 P/Share
|
|
Jun 10
2021
|
Robert J Michel Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+24.24%
|
-
|
|
Apr 19
2021
|
Robert J Michel Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+19.05%
|
$10,000
$10.25 P/Share
|
|
Apr 16
2021
|
Michael Richard Feldschuh Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,200
+2.59%
|
$42,000
$10.33 P/Share
|